Anthill, HCG launch programme for HealthTech start-ups
Anthill Ventures, an investment and scaling platform for early growth stage start-ups, has announced its partnership with HealthCare Global Enterprises Ltd. (HCG), the largest provider of cancer care in India, to launch a market access programme for HealthTech start-ups. Lumos is a 12-month programme designed for HealthTech startups with disruptive solutions and technologies within the core businesses of HCG which include oncology, fertility, precision medicine, genomics, research and diagnostics, as well as emerging areas across the healthcare ecosystem. Anthill and HCG, along with their network of investors will invest up to $1 million in the HealthTech start-ups. The start-ups will also have access to new customers, get business mentoring and support in their growth journey, access to high end environment for faster product development, platform to showcase their products to the right market and opportunity to work on pilot projects through partnerships with corporates.